D-1317-2020 Class II Terminated
FDA drug recall D-1317-2020 was initiated by Torrent Pharma Inc. on May 11, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Aug 10, 2022). Affected quantity: 6228 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2020
- Initiation Date
- May 11, 2020
- Termination Date
- Aug 10, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6228 Bottles
Product description
Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05
Reason for recall
Failed Dissolution Specifications
Distribution pattern
USA Nationwide and Puerto Rico
Code information
Lot #: 4FF4F001, Exp 1/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1317-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026